Pancreatic Neuroendocrine Neoplasm
4 clinical trials · Condition
◉ Watch Pancreatic Neuroendocrine Neoplasm
| Record | Firm | Date |
|---|---|---|
| Nimotuzumab in EGFR Highly Expressed Pancreatic Neuroendocrine Neoplasms (NCT05316480) | Fudan University | 2022-05-01 |
Track Pancreatic Neuroendocrine Neoplasm automatically
Every clearance here is in the API, with alerts when new ones post.